Differences in Quality of Life and Emotional Well-being in Breast, Colon, and Lung Cancer Patients During Outpatient Adjuvant Chemotherapy

Abstract

BackgroundAdjuvant chemotherapy used at each cancer site may affect quality of life (QoL) and emotional well-being (affect) of cancer patients differently; however, these differences between groups have not been studied.ObjectivesThe aim of this study was to assess differences in QoL and affect by cancer site at the start of outpatient adjuvant chemotherapy, whether QoL and affect change during this treatment, and whether adverse effects influence these variables.MethodsA multicenter longitudinal descriptive study was conducted with 247 participants with breast, colon, or lung cancer at the beginning (T1) and end of treatment (T2). We used the SF-12 Health Survey, Positive and Negative Affect Scale, and an “ad hoc” adverse effects questionnaire.ResultsAt the start of chemotherapy, the lung group had poorer Physical Component Summary and poorer positive and negative affect (P < .05) scores. In the end-of-treatment comparisons, breast and colon cancer patients’ status had worsened, whereas lung cancer patients had tended to stabilize, although they remained the most vulnerable. Adverse effect severity was significant for Physical Component Summary (r = −0.13, P = .035), with decreases in positive affect (r = −0.17, β = −.16) and increases in negative affect (r = 0.15, β = .14).ConclusionsChanges in QoL and emotional state differ between groups, implying a need for varying levels of follow-up and emotional support. Patients with lung cancer seem particularly vulnerable.Implications for PracticeCancer nurses could strengthen the assessment of patients undergoing chemotherapy using more sensitive instruments such as the Positive and Negative Affect Scale and considering differences by cancer site, to provide care tailored to individual patient needs and preferences.

Influence of pelvic floor disorders on quality of life in women

“…Concerning musculoskeletal pathologies, in line with our results, a study with a nationally representative sample of 17550 participants carried out in the United States, where the same evaluation method was used as in our study, affirmed that those who had musculoskeletal conditions had lower HRQoL scores ( 52 ). Likewise, neoplastic diseases, as shown by our results and by other authors ( 53 ), are negatively associated with HRQoL. This was also identified in a sample of 1078 women diagnosed with breast cancer in a multi-case control study carried out in Spain, which rated their HRQoL as poor ( 54 ).…”

The effect of continuous care on the recovery of patients with advanced colorectal cancer undergoing chemotherapy

“…This not only affects their physical health but also their psychological and social well-being, negatively impacting their quality of life and emotional health. [7][8][9] This means that cancer patients undergoing chemotherapy feel that their physical health is poor, and they are more limited in moderate or intense physical activity than expected. Additionally, few longitudinal studies show that patients' physical and mental conditions gradually deteriorate from the beginning of chemotherapy to mid-chemotherapy and the end of chemotherapy.…”

“…This not only affects their physical health but also their psychological and social well-being, negatively impacting their quality of life and emotional health. [ 7 – 9 ]…”